Literature DB >> 26113169

The effect of jugular bulb-vestibular aqueduct dehiscence on hearing and balance.

Shufeng Li1,2, Na Shen1,2, Yushu Cheng3, Yan Sha3, Zhengmin Wang1,2.   

Abstract

CONCLUSION: This study suggests that jugular bulb-vestibular aqueduct dehiscence (JBVAD) does not affect the hearing or balance functions of the inner ear.
OBJECTIVES: Since JBVAD may cause impairment of the inner ear and induce hearing loss, tinnitus, and vertigo, this study was to investigate the effect of JBVAD on hearing and balance.
METHOD: Patients undergoing temporal bone computed tomography (TBCT) scans from May 2013 to December 2013 at a tertiary referral hospital were reviewed. The topographic relationship between the jugular bulb (JB) and the vestibular aqueduct was assessed. The findings were classified as normal when there was always a bony structure between the two structures and as dehiscent when the bony coverage separating the two structures was absent. Clinical data were collected via electronic records and clinical follow-up.
RESULTS: A total of 1313 out of 8325 patients were diagnosed with a HJB. Forty-six patients showed JBVAD. The prevalence of dehiscence was 0.6% in patients undergoing temporal bone CT scans and 3.5% in patients with HJB. Of the 46 patients with JBVAD, 23 (50%) had sensorineural hearing loss, three (6.5%) had tinnitus, and two (4.3%) had vertigo. The correlation between JBVAD and these clinical symptoms did not achieve statistical significance.

Entities:  

Keywords:  Computed tomography; JBVAD; Jugular bulb; dehiscence; dizziness; hearing; temporal bone; tinnitus; vertigo; vestibular aqueduct

Mesh:

Year:  2015        PMID: 26113169     DOI: 10.3109/00016489.2015.1062141

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

Review 1.  High jugular bulb with a diverticulum and vestibular aqueduct dehiscence: an anatomical variant to be aware in patients with hearing loss.

Authors:  Angela Guarnizo; Juan Andrés Mejía; Oscar Torres
Journal:  Surg Radiol Anat       Date:  2022-07-16       Impact factor: 1.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.